Skip to main content

4526 · Riken Vitamin Co., Ltd. · Financials

3,660 JPY +25 (+0.69%) At close · Nov 13
Market Cap
104.54B JPY
Shares
28.56M
Volume · Nov 13 99.5K Avg daily vol (3M) 94.73K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
96.3B +0.8%
FY2026 Revenue FY2022–FY2026
Net Income
7.04B -25.1%
FY2026 Net Income FY2022–FY2026
Gross Margin
30.91% -1.8pp
FY2026 Gross Margin FY2022–FY2026
Operating Margin
7.17% -2pp
FY2026 Operating Margin FY2022–FY2026
Operating Cash Flow
5.96B -24.4%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025 FY2024 FY2023 FY2022
JPY 96.3B 95.58B 91.48B 88.75B 79.23B
JPY 66.53B 64.31B 61.6B 61.51B 53.67B
JPY 29.77B 31.27B 29.89B 27.24B 25.56B
JPY 6.9B 8.72B 9.37B 7.16B 5.84B
JPY 10.24B 12.71B 11.91B 7.86B 20.31B
JPY 3.2B 3.31B 3.15B 1.44B -1.29B
JPY 7.04B 9.39B 8.76B 6.41B 21.58B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 11.18B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.